This is a Live, Real Time Chiropractic Continuing Education TeleSeminar/Webinar. You will login to our online meeting room and connect to audio via VoiP.
Click here for printable instructions for taking our Teleseminar/Webinar
NOTE: Our platform is optimized for use with PC, MAC, Ipad/Iphone and Android Devices. Known issues exist with Chromebook. If you have another platform, please contact us for compatiblity
If you arrive late and/or do not meet the requirements to receive the full hours of CE for this teleseminar/webinar, a certificate for hours earned will be issued but no partial tuition refund will be given. If you register for the teleseminar and do not attend, we will place the tuition in your CE Bank or return the prepaid credits to your account so that you can apply them towards another teleseminar/webinar or online course.
Hour 1
- Describe the physiologic role of endogenous GLP-1 and GIP in glucose regulation, appetite control, and energy balance.
- Explain the mechanism of action of GLP-based medications at the pancreatic, GI, and CNS levels.
- Differentiate short-acting and long-acting GLP-based medications on pharmacokinetics, dosing, and clinical effects.
- Identify FDA-approved GLP-based medications and their approved indications.
- Recognize emerging multi-system effects that may influence musculoskeletal health and rehabilitation outcomes.
Hour 2
- Summarize the clinical benefits of GLP-based medications for weight loss and cardiometabolic risk reduction.
- Identify common, uncommon, and serious adverse effects associated with GLP-based therapy.
- Explain implications of GLP/GIP-associated lean mass and bone density loss for musculoskeletal health.
- Recognize red flags requiring referral or co-management with medical providers.
- Integrate appropriate counseling, exercise recommendations, and interprofessional referral strategies.
Hour 3
- Explain how muscle and activity play a crucial role in regulating metabolism
- Compare normal dietary intake and restricted dietary intake.
- Define influence of GLP-1 and weight loss drugs
- Explain how GLP-1s and resulting muscle changes can impact physical exam findings and plans of care
Hour 4
- Define and explain the impact of sarcopenia
- List physical exam findings and describe the components of SARC-F.
- Understand and explain ACSM and NSCA guidelines and potential intervention optimizations
- Identify the pros and cons of GLP-1 use and muscle outcomes
- AKAlaska
- BCBritish Columbia
- CACalifornia
- COColorado
- CTConnecticut
- DCDistrict of Columbia
- DEDelaware
- GAGeorgia
- GUGuam
- IAIowa
- IDIdaho
- ILIllinois
- INIndiana
- KSKansas
- MAMassachusetts
- MBManitoba
- MDMaryland
- MEMaine
- MIMichigan
- MNMinnesota
- MOMissouri
- MTMontana
- NBNew Brunswick
- NCNorth Carolina
- NDNorth Dakota
- NENebraska
- NHNew Hampshire
- NJNew Jersey
- NSNova Scotia
- NYNew York
- OHOhio
- ONOntario
- OROregon
- PRPuerto Rico
- RIRhode Island
- SCSouth Carolina
- SDSouth Dakota
- TNTennessee
- UTUtah
- VAVirginia
- VIVirgin Islands
- VTVermont
- WAWashington
- WIWisconsin
- WYWyoming
- YTYukon